Quick Answer
ADMA BIOLOGICS, INC. reported Research And Development Expense of $4.76 million for the year ending 2025.
- ADMA BIOLOGICS, INC. showed an increase of +162.7% in Research And Development Expense from 2024 to 2025.
- This data is from ADMA BIOLOGICS, INC.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2011 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2011 to 2025), ADMA BIOLOGICS, INC.'s Research And Development Expense has grown by 636.3%.
- Historical annual values: Fiscal year 2025: $4.76 million | Fiscal year 2024: $1.81 million | Fiscal year 2023: $3.30 million | Fiscal year 2022: $3.61 million | Fiscal year 2021: $3.65 million | Fiscal year 2020: $5.91 million | Fiscal year 2019: $2.34 million | Fiscal year 2019: $1.00 million | Fiscal year 2018: $3.93 million | Fiscal year 2017: $5.57 million | Fiscal year 2016: $7.69 million | Fiscal year 2015: $7.02 million | Fiscal year 2014: $9.52 million | Fiscal year 2013: $9.30 million | Fiscal year 2012: $2.00 million | Fiscal year 2012: $3.47 million | Fiscal year 2011: $646.8 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: